Companies · Healthtech

Jana Care, Inc.

WATERTOWN · Healthtech · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Jana Care, Inc. — recommendation, valuation, rhythm, risks.
$35.7M
Total raised · real
8
Rounds
0.5×
Latest step-up
Top 14%
Sector rank · raised
Series A
Latest stage · inferred · Thu Mar 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Jana Care, Inc. looks under-valued against its niche peers and is active on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.19× the median modeled value of Series A Healthtech companies in 2025–2027 (99 peers) — value vs value, same stage and era.
Active
  • Last raise 4 mo ago; this sector typically re-raises about every 14 months.
  • Raising on or ahead of the sector's normal rhythm.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Jana Care, Inc. is one of 2138 Healthtech companies tracked from WATERTOWN. By capital raised it ranks in the upper tier (ahead of 87% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
24
Investors (latest)
2026-03-12
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MSeed · 2016-03-17 Raised $3.4M (real) Modeled valuation $95M (est)Seed2016Series A · 2018-05-14 Raised $9.9M (real) Modeled valuation $223M (est)Series A2018Series A · 2018-05-14 Raised $13M (real) Modeled valuation $287M (est)Series A2018Series A · 2020-10-13 Raised $660K (real) Modeled valuation $13M (est)Series A2020Series A · 2021-11-04 Raised $869K (real) Modeled valuation $12M (est)Series A2021Series A · 2022-11-16 Raised $575K (real) Modeled valuation $5.3M (est)Series A2022Series A · 2023-10-18 Raised $13M (real) Modeled valuation $86M (est)Series A2023Series A · 2025-03-05 Raised $2.9M (real) Modeled valuation $11M (est)Series A2025Series A · 2026-03-12 Raised $1.4M (real) Modeled valuation $3.7M (est)Series A2026+$9.9M+$13M+$660K+$869K+$575K+$13M+$2.9M+$1.4MCumulative $46M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$3.4M · 2016
Series A$9.9M · 2018
Series A extension$12.7M · 2018
Series A extension$660K · 2020
Series A extension$869K · 2021
Series A extension$575K · 2022
Series A extension$13.1M · 2023
Series A extension$2.9M · 2025
Series A extension$1.4M · 2026

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$3.7M
Base estimate est.
$1.8M
Conservative case
$5.4M
Upside case
$6.3M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Seed · modeled $95.0M · 2016-03-172016Series A · modeled $223.2M · 2018-05-14Series A · modeled $287.4M · 2018-05-14Series A · modeled $13.4M · 2020-10-13Series A · modeled $11.8M · 2021-11-04Series A · modeled $5.3M · 2022-11-16Series A · modeled $85.6M · 2023-10-18Series A · modeled $11.2M · 2025-03-05Series A · modeled $3.7M · 2026-03-122026
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.46×/yr
Annual markup
1.84×/yr upside case
0.3 yr
Elapsed time used
0.3 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
15 mo
Avg between rounds
$3.6M/yr
Capital velocity
10.3 yr
On record since
2016
First round
9
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 8.0× above median
This company$35.7M
Sector median$4.5M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.3× of median
This company$1.4M
Sector median$5.5M
Modeled value — vs sector median (estimate, all stages) 0.1× of median
This company$3.7M
Sector median$33.8M

Raised more than 87% of sector peers (real $). Modeled value above 20% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #90 of 99.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0M$10.0M$100.0MCapital raised (log)Queen Dental USA Inc · Series A Raised $15.0M · modeled $61.4M (est)Healthplan Data Solutions, Inc. · Series A Raised $16.7M · modeled $56.1M (est)Chronic Care Management, Inc. · Series A Raised $40.6M · modeled $53.7M (est)Mountain Health Technologies, Inc. · Series A Raised $15.2M · modeled $46.4M (est)Modular Medical, Inc. · Series A Raised $17.3M · modeled $45.7M (est)Healthcare Triangle, Inc. · Series A Raised $19.2M · modeled $44.4M (est)Handl Health, Inc. · Series A Raised $15.7M · modeled $40.3M (est)Medical Exercise Inc. · Series A Raised $11.1M · modeled $40.3M (est)Frontera Health, Inc. · Series A Raised $10.0M · modeled $40.1M (est)Prospyr Medical, Inc. · Series A Raised $18.6M · modeled $39.5M (est)Koda Health, Inc. · Series A Raised $12.2M · modeled $39.3M (est)Cooler Heads Care, Inc. · Series A Raised $18.8M · modeled $39.0M (est)Jana Care, Inc. (this company) Raised $35.7M · modeled $3.7M (est)Jana Care, Inc.
CompanyStageRaised · realValue · estvs peer med.
Queen Dental USA IncSeries A$15.0M$61.4M3.19×
Healthplan Data Solutions, Inc.Series A$16.7M$56.1M2.92×
Chronic Care Management, Inc.Series A$40.6M$53.7M2.79×
Mountain Health Technologies, Inc.Series A$15.2M$46.4M2.42×
Modular Medical, Inc.Series A$17.3M$45.7M2.38×
Healthcare Triangle, Inc.Series A$19.2M$44.4M2.31×
Handl Health, Inc.Series A$15.7M$40.3M2.10×
Medical Exercise Inc.Series A$11.1M$40.3M2.10×
Frontera Health, Inc.Series A$10.0M$40.1M2.09×
Prospyr Medical, Inc.Series A$18.6M$39.5M2.06×
Koda Health, Inc.Series A$12.2M$39.3M2.04×
Cooler Heads Care, Inc.Series A$18.8M$39.0M2.03×
Jana Care, Inc. this companySeries A$35.7M$3.7M0.19×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$3.4M2016-03-17$17.1M$95.0M90%
Series A$9.9M2018-05-14$44.9M$223.2M90%
Series A$12.7M2018-05-14$57.9M$287.4M90%
Series A$660K2020-10-13$3.0M$13.4M90%
Series A$869K2021-11-04$3.9M$11.8M90%
Series A$575K2022-11-16$2.6M$5.3M90%
Series A$13.1M2023-10-18$59.8M$85.6M90%
Series A$2.9M2025-03-05$13.2M$11.2M90%
Series A$1.4M2026-03-12$6.3M$3.7M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$3.4M2016-03-17
    • First recorded raise — entered as Seed.
    • 6 investors on this round.
  2. Series A$9.9M2018-05-14
    • Raised again after 26 mo — slower than the ~14 mo sector norm.
    • Round 2.9× larger than the prior — scaling up.
    • 14 investors on this round.
  3. Series A$12.7M2018-05-14
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 20 investors on this round.
  4. Series A$660K2020-10-13
    • Raised again after 29 mo — slower than the ~14 mo sector norm.
    • Round 19.3× smaller than the prior — bridge or down round.
    • 5 investors on this round.
  5. Series A$869K2021-11-04
    • Raised 13 mo later, in step with the ~14 mo sector norm.
    • Round 1.3× larger than the prior — scaling up.
    • 7 investors on this round.
  6. Series A$575K2022-11-16
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 1.5× smaller than the prior — bridge or down round.
    • 14 investors on this round.
  7. Series A$13.1M2023-10-18
    • Raised 11 mo later, in step with the ~14 mo sector norm.
    • Round 22.8× larger than the prior — scaling up.
    • 23 investors on this round.
  8. Series A$2.9M2025-03-05
    • Raised 17 mo later, in step with the ~14 mo sector norm.
    • Round 4.5× smaller than the prior — bridge or down round.
    • 9 investors on this round.
  9. Series A$1.4M2026-03-12
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 2.1× smaller than the prior — bridge or down round.
    • 24 investors on this round.
Intelligence
2027 ~Q2
Modeled next raise · ~15mo cadence
$1.4M
Modeled next size est.range $1.4M$2.2M
0.5×
Last step-up
$3.6M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Richard Williams9 other2023-10
Rajen Dalal4 other2018-05
Arda Minocherhomjee3 other2018-05
Timothy Richards3 other2022-11
Ehsan Jabbarzadeh2 other2023-10
Anh Hoang-Lindsay1 other2021-11
Jean-Luc Butel1 other2016-03
Michal Depa1 other2016-03
Sidhant Jena1 other2016-03
Darrell Elliott2016-03
Geoff Woolley2018-05
Rajiv Mody2018-05
Srinivas Ramdas Sunder2021-11
Veronica Chew2023-10
William Kridel2021-11
Registry & provenance

Jana Care, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1696563
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Imagen Dental Partners, LlcHealthtechSeries A$33.3M$312Ksame sector · same stage
Provisio Medical, Inc.HealthtechSeries A$39.5M$4.8Msame sector · same stage
Foresee Medical, Inc.HealthtechSeries A$45.9M$6.1Msame sector · same stage
Intus Care Inc.HealthtechSeries A$25.2M$1.4Msame sector · same stage
Vsee Health, Inc.HealthtechSeries A$23.6M$2.7Msame sector · same stage
OpenLoop Health, Inc.HealthtechSeries A$21.3M$2.3Msame sector · same stage
G Medical Innovations Holdings Ltd.HealthtechSeries A$20.6M$3.3Msame sector · same stage
KitoTech Medical, Inc.HealthtechSeries A$20.5M$1.0Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Flexwise Health, Inc.HealthtechSeed$4.4M85%
Couplet Care, Inc.HealthtechPre-Seed$5.1M85%
Care One Services LLCHealthtechPre-Seed$7.8M84%
Kensana Health Inc.HealthtechSeries D+$944.4M84%
Innovative Health LlcHealthtechSeries A$112.9M84%
Pre Health Technology, Inc.HealthtechSeries A$50.5M84%
Jade Healthcare, Inc.HealthtechSeries A$108.3M84%
Momtech Inc.Other Health CareSeries A$2.2M84%
Frequently asked
How much funding has Jana Care, Inc. raised?
Jana Care, Inc. has raised approximately $35.7M in disclosed capital across 8 recorded financing rounds, aggregated from public filings.
What is Jana Care, Inc.'s estimated valuation?
Provath's modeled valuation for Jana Care, Inc. is approximately $3.7M (modeled range $1.8M–$5.4M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Jana Care, Inc. at?
Jana Care, Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Thu Mar 12.
What does Jana Care, Inc. do and where is it based?
Jana Care, Inc. operates in the Healthtech sector, based in WATERTOWN.
Explore related

See where Jana Care, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Jana Care, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.